Calendula officinalis is a short-lived aromatic herbaceous plant native to the Mediterranean and southwestern Asia, cultivated widely across Europe and North America. Its bright orange and yellow flower heads contain a complex array of bioactive compounds that give it potent wound-healing, anti-inflammatory, and antimicrobial properties. It has been used in European folk medicine, Ayurvedic practice, and modern integrative oncology for skin and mucosal conditions.

Calendula's triterpenoids — particularly oleanolic acid and ursolic acid — inhibit pro-inflammatory mediators including cyclooxygenase (COX) enzymes and NF-κB signaling pathways, reducing local inflammation at wound sites. Its polysaccharides stimulate fibroblast proliferation and collagen deposition, accelerating tissue granulation and re-epithelialization. Flavonoids and carotenoids contribute antioxidant activity, reducing oxidative stress in damaged tissue, while saponins appear to enhance membrane permeability, improving absorption of active compounds.

Topical preparations (creams, ointments, gels) are the most clinically studied and widely used forms. Standardized creams typically contain 2–5% calendula flower extract. Tinctures (1:5 or 1:10 in ethanol) are used for oral rinses and diluted topical application. Oral capsules are available but have significantly less clinical trial evidence than topical forms. Calendula tea made from dried flower heads is used traditionally for gastric and mucosal complaints. For radiation dermatitis, a standardized aqueous cream formulation has been studied in oncology settings.

• Wound healing
• Radiation-induced dermatitis
• Oral mucositis
• Contact dermatitis and eczema
• Diaper dermatitis (infant skin irritation)
• Venous leg ulcers
• Surgical wound recovery

• Prevention of grade 2+ acute radiation dermatitis in breast cancer patients undergoing radiotherapy (Pommier et al., 2004)
• Prevention of oral mucositis severity in patients receiving chemotherapy or head-and-neck radiation (emerging evidence, not yet definitive)

• Calendula petals (edible, fresh or dried) — The flower petals of Calendula officinalis are edible and are the direct source of all bioactive triterpenoids, flavonoids, and carotenoids; used as food coloring, in salads, and as tea — the most concentrated dietary form available.
• Calendula herbal tea — Dried calendula flower heads steeped in hot water release water-soluble polysaccharides, flavonoids, and some saponins, providing a mild oral dose of active compounds; traditional preparation for mucosal and digestive support.

• Allergic contact dermatitis (in Asteraceae-sensitive individuals)
• Mild skin irritation or redness at application site (rare)
• Anaphylaxis in severe allergy cases (very rare, documented case reports)
• Mild sedation with high-dose oral use (theoretical, limited human evidence)
• Potential uterotonic effects with high oral doses — oral use not recommended in pregnancy beyond culinary amounts
• Gastrointestinal upset with high-dose oral supplementation (rare)

• Recommended daily: Topical: Apply 2–5% calendula flower extract cream or ointment to affected area 2–3 times daily. Tincture (1:5): 1–4 mL diluted in water, used topically or as oral rinse 3 times daily. Oral capsules: 300–600 mg standardized extract daily (limited clinical data; follow product labeling). Calendula tea: 1–2 teaspoons dried flowers steeped in 250 mL hot water for 10–15 minutes, 2–3 cups daily.
• Best time of day: Topical application: Apply after cleansing the skin, ideally morning and evening. Oral tea or rinse: 2–3 times daily with or between meals for mucosal conditions.
• With or without food: Oral supplemental or tincture forms are generally better tolerated with food to reduce risk of GI discomfort. Topical use is not affected by food timing.
• Time to effect: Topical wound and inflammation: 5–14 days for visible improvement; oral mucosal effects: 3–7 days; radiation dermatitis prevention: effects seen over course of radiotherapy (weeks).
• How long to take it: Topical use for acute wound healing: continue until wound closure, typically 2–6 weeks. For radiation dermatitis: use throughout and up to 4 weeks post-radiotherapy. Long-term continuous oral use beyond 3 months lacks robust safety data; cycling or taking periodic breaks is prudent. Consult a healthcare provider for chronic skin conditions requiring extended use.